Avalon Trust’s Organon & Co OGN Stock Holding History

Avalon Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$73	–	445
2025 Q1	$73	Buy	+5	New	+$77	﹤0.01%	427
2024 Q1	–	Sell	-13	Closed	-$188	–	345
2023 Q4	$188	Buy	+13	New	+$177	﹤0.01%	339

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Avalon Trust's OGN Position: Q2 2025 in Review

Avalon Trust sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 5 shares — an estimated $73 sold.

Avalon Trust first reported a position in OGN in Q4 2023 and held it in 2 quarters. The position peaked at $188 in Q4 2023. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Avalon Trust reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Avalon Trust sold 5 Organon & Co shares in Q2 2025, an estimated $73.
Avalon Trust first reported a position in Organon & Co in Q4 2023 and held it in 2 quarters.
Avalon Trust's Organon & Co position peaked at $188 in Q4 2023.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Avalon Trust's 13F filing for Q2 2025, filed 8 Aug 2025.